MIT spinouts to head down Infinite Corridor

A new venture fund established by VC firm Good Growth Capital is set to back science and tech-based concepts spawned from Massachusetts Institute of Technology  (MIT).
Infinity Corridor Fund remains open to investments having reached an initial close of undisclosed size, adopting a focus on early-stage MIT businesses in spaces such as health sciences, software, data sciences, hard sciences, agtech and green technologies.
In keeping with its precursors, none of the fund’s limited partners have been identified. Good Growth’s first fund, General Fund I, launched in 2017 with a reported $20m target to invest in US east coast businesses with unspecified co-investment partners in Charleston, Boston and New York.
Good Growth followed up with the launch of Good Growth General Fund II earlier this year, though further details could not be ascertained.
Among Good Growth’s portfolio companies are financial wellness technology business Questis, physical therapy app developer PT on Demand, parental control software creator Dynepic and predictive sales analytics app developer Interloop.
Amy Salzhauer, founder and managing partner of Good Growth Capital, said: “We are thrilled with the outsized performance of our first General Fund and have equal confidence in the Infinite Corridor Fund.
“Many funds run from the deals requiring the kind of complex scientific understanding that we embrace as one of our key competitive advantages.”